Long-term clinical experience with vedolizumab (VDZ) in patients with mild to moderate ulcerative colitis (UC)

Authors
Category Primary study
JournalJournal of Crohn's and Colitis
Year 2012
This article has no abstract
Epistemonikos ID: 9940052403480a8d9dccb70d92fcb81db07550bd
First added on: Jan 28, 2022